Vitamin D profile in autism spectrum disorder children and its relation to the disease severity
Background The study aimed to investigate whether vitamin D deficiency is a common finding in autism spectrum disorder (ASD) children and whether such deficiency is related to ASD severity and language age or not. Methods A cross-sectional observational study was conducted on ASD children aged 2-6 years. The participants were 80 Egyptian children with ASD. All participants were assessed using DSM-V, the Childhood Autism Rating Scale (CARS), language assessment, and assessment of serum vitamin D using ADVIA Centaur Vit D assay. Results About 63.8% of ASD children have vitamin D insufficiency, 28.8 % have vitamin D deficiency, and 7.4% have normal serum levels. No correlation was found between serum vitamin D and language age (r = -0.085, P = 0.451), DSM 5 severity levels (r = 0.$ 015^{,} $P= 0.894), and CARS scores (r= 0.075, P= 0.511). Conclusion ASD children have lower serum vitamin D levels, which may be one of the environmental factors contributing to ASD development in genetically susceptible individuals, and its correction may be helpful as adjuvant therapy for ASD..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
The Egyptian journal of otolaryngology - 40(2024), 1 vom: 18. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mansour, Amira [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
Anmerkungen: |
© The Author(s) 2024 |
---|
doi: |
10.1186/s43163-024-00573-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR054442915 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | SPR054442915 | ||
003 | DE-627 | ||
005 | 20240119064716.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240119s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s43163-024-00573-w |2 doi | |
035 | |a (DE-627)SPR054442915 | ||
035 | |a (SPR)s43163-024-00573-w-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mansour, Amira |e verfasserin |4 aut | |
245 | 1 | 0 | |a Vitamin D profile in autism spectrum disorder children and its relation to the disease severity |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2024 | ||
520 | |a Background The study aimed to investigate whether vitamin D deficiency is a common finding in autism spectrum disorder (ASD) children and whether such deficiency is related to ASD severity and language age or not. Methods A cross-sectional observational study was conducted on ASD children aged 2-6 years. The participants were 80 Egyptian children with ASD. All participants were assessed using DSM-V, the Childhood Autism Rating Scale (CARS), language assessment, and assessment of serum vitamin D using ADVIA Centaur Vit D assay. Results About 63.8% of ASD children have vitamin D insufficiency, 28.8 % have vitamin D deficiency, and 7.4% have normal serum levels. No correlation was found between serum vitamin D and language age (r = -0.085, P = 0.451), DSM 5 severity levels (r = 0.$ 015^{,} $P= 0.894), and CARS scores (r= 0.075, P= 0.511). Conclusion ASD children have lower serum vitamin D levels, which may be one of the environmental factors contributing to ASD development in genetically susceptible individuals, and its correction may be helpful as adjuvant therapy for ASD. | ||
650 | 4 | |a Vitamin D |7 (dpeaa)DE-He213 | |
650 | 4 | |a Autism spectrum disorder |7 (dpeaa)DE-He213 | |
650 | 4 | |a DSM5 severity levels |7 (dpeaa)DE-He213 | |
700 | 1 | |a Amer, Ayman |0 (orcid)0009-0004-1117-5313 |4 aut | |
700 | 1 | |a Sobh, Ali |0 (orcid)0000-0001-7047-076X |4 aut | |
700 | 1 | |a Zaki, Maysaa |0 (orcid)0000-0001-5431-0248 |4 aut | |
700 | 1 | |a Abou-Elsaad, Tamer |0 (orcid)0000-0002-8591-966X |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Egyptian journal of otolaryngology |d Mumbai, India : Wolters Kluwer - Medknow Publications, 2012 |g 40(2024), 1 vom: 18. Jan. |w (DE-627)SPR039921611 |w (DE-600)2875428-1 |x 2090-8539 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2024 |g number:1 |g day:18 |g month:01 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s43163-024-00573-w |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 40 |j 2024 |e 1 |b 18 |c 01 |